Showing results (11-20 of 417) with videos related to
Sort By:
Pageof 42
Annals of Hepatology|April 21, 2017
MRE in NAFLD: Promising but Further Validation is RequiredJohn D Ryan, Emmanuel A TsochatzisThe Lancet. Gastroenterology & Hepatology|August 8, 2019
Management of metabolic syndrome and cardiovascular risk after liver transplantationEvangelia M Fatourou, Emmanuel A TsochatzisHepatobiliary Surgery and Nutrition|January 9, 2015
ART and science in using transarterial chemoembolization for retreating patients with hepatocellular carcinomaEvangelia M Fatourou, Emmanuel A TsochatzisThe Lancet. Gastroenterology & Hepatology|June 13, 2018
Non-alcoholic fatty liver disease and the interface between primary and secondary careEmmanuel A Tsochatzis, Philip N NewsomeHormones (Athens, Greece)|June 3, 2018
The effect of antidiabetic medications on non-alcoholic fatty liver disease (NAFLD)Laura Iogna Prat, Emmanuel A TsochatzisWorld Journal of Gastrointestinal Pharmacology and Therapeutics|May 18, 2011
Is there any progress in the treatment of non-alcoholic fatty liver disease?Emmanuel A Tsochatzis, George V PapatheodoridisMetabolism: Clinical and Experimental|January 30, 2016
The multiple-hit pathogenesis of non-alcoholic fatty liver disease (NAFLD)Elena Buzzetti, Massimo Pinzani, Emmanuel A TsochatzisCurrent Opinion in Pharmacology|October 23, 2021
Non-alcoholic fatty liver disease: Current therapeutic optionsAvik Majumdar, Jef Verbeek, Emmanuel A TsochatzisMinerva Endocrinologica|November 24, 2016
Intestinal hormones, gut microbiota and non-alcoholic fatty liver diseaseNikolaos Koukias, Elena Buzzetti, Emmanuel A TsochatzisEuropean Journal of Internal Medicine|January 21, 2024
Non-invasive testing and risk-stratification in patients with MASLDMirko Zoncapè, Antonio Liguori, Emmanuel A TsochatzisPageof 42